Cargando…
Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles
Cancer heterogeneity and drug resistance limit the efficacy of cancer therapy. To address this issue, we have developed an integrated treatment protocol for effective treatment of heterogeneous ovarian cancer. Methods: An amphiphilic polymer coated magnetic iron oxide nanoparticle was conjugated wit...
Autores principales: | Satpathy, Minati, Wang, Liya, Zielinski, Rafal J., Qian, Weiping, Wang, Y. Andrew, Mohs, Aaron M., Kairdolf, Brad A., Ji, Xin, Capala, Jacek, Lipowska, Malgorzata, Nie, Shuming, Mao, Hui, Yang, Lily |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376473/ https://www.ncbi.nlm.nih.gov/pubmed/30809308 http://dx.doi.org/10.7150/thno.29964 |
Ejemplares similares
-
Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery
por: Gao, Ning, et al.
Publicado: (2017) -
Theranostic Nanoparticles Carrying Doxorubicin Attenuate Targeting Ligand Specific Antibody Responses Following Systemic Delivery
por: Yang, Emmy, et al.
Publicado: (2015) -
uPAR-targeted Optical Imaging Contrasts as Theranostic Agents for Tumor Margin Detection
por: Yang, Lily, et al.
Publicado: (2013) -
In Vivo Assessment of HER2 Receptor Density in HER2-positive Tumors by Near-infrared Imaging, Using Repeated Injections of the Fluorescent Probe
por: Ardeshirpour, Yasaman, et al.
Publicado: (2014) -
Affibody-DyLight Conjugates for In Vivo Assessment of HER2 Expression by Near-Infrared Optical Imaging
por: Zielinski, Rafal, et al.
Publicado: (2012)